IFNG and neoplasm: The nanocomplexes of macrophage-targeting nanocarriers and CAR-IFN-γ-encoding plasmid DNA can be injected in vivo to induce CAR-macrophages that are adequate for anti-tumor immunomodulation, CAR-mediated cancer phagocytosis, and inhibition of solid tumor growth.